|
2009 Journal Article A rapid, cost-effective method for counting human embryonic stem cell numbers as clumpsProwse, ABJ, Wolvetang, EJ and Gray, PP (2009). A rapid, cost-effective method for counting human embryonic stem cell numbers as clumps. Biotechniques, 47 (1), 599-606. doi: 10.2144/000113151 |
|
2009 Journal Article Adipocyte differentiation in human embryonic stem cells transduced with Oct4 shRNA lentivirusHannan, Nicholas R.F. and Wolvetang, Ernst J. (2009). Adipocyte differentiation in human embryonic stem cells transduced with Oct4 shRNA lentivirus. Stem Cells Development, 18 (4), 653-660. doi: 10.1089/scd.2008.0160 |
|
2008 Journal Article Stimulation of autophagy suppresses the intracellular survival of Burkholderia pseudomallei in mammalian cell linesCullinane, Meabh, Gong, Lan, Lazar-Adler, Natalie, Tra, Thien, Wolvetang, Ernst, Prescott, Mark, Boyce, John D., Devenish, Rodney J. and Adler, Ben (2008). Stimulation of autophagy suppresses the intracellular survival of Burkholderia pseudomallei in mammalian cell lines. Autophagy, 4 (6), 744-753. doi: 10.4161/auto.6246 |
|
2008 Journal Article p53 is required for etoposide-induced apoptosis of human embryonic stem cellsGrandela, C., Pera, M. F. and Wolvetang, E. J. (2008). p53 is required for etoposide-induced apoptosis of human embryonic stem cells. Stem Cell Research, 1 (2), 116-128. doi: 10.1016/j.scr.2007.10.003 |
|
2007 Journal Article Gap junction mediated transport of shRNA between human embryonic stem cellsWolvetang, Ernst J., Pera, Martin F. and Zuckerman, Kenneth S. (2007). Gap junction mediated transport of shRNA between human embryonic stem cells. Biochemical and biophysical research communications, 363 (3), 610-615. doi: 10.1016/j.bbrc.2007.09.035 |
|
2007 Journal Article hESC Adaptation, Selection and StabilityGrandela, C. and Wolvetang, E. (2007). hESC Adaptation, Selection and Stability. Stem Cell Reviews and Reports, 3 (3), 183-191. doi: 10.1007/s12015-007-0008-4 |
|
2006 Journal Article CD30 is a survival factor and a biomarker for transformed human pluripotent stem cellsHerszfeld, Daniella, Wolvetang, Ernst, Langton-Bunker, Emma, Chung, Tung-Liang, Filipczyk, Adam A,, Houssami, Souheir, Pegah Jamshid, Koh, Karen, Laslett, Andrew L., Anna Michalska, Nguyen, Linh, Reubinoff, Benjamin E., Tellis, Irene, Auerbach, Jonathan M., Ording, Carol J., Looijenga, Leendert H. J. and Pera, Martin F. (2006). CD30 is a survival factor and a biomarker for transformed human pluripotent stem cells. Nature Biotechnology, 24 (3), 351-357. doi: 10.1038/nbt1197 |
|
2005 Journal Article Mitochondrial dysfunction in mouse oocytes results in preimplantation embryo arrest in vitro. (vol 71, pg 1936, 2004)Thouas, GA, Trounson, AO, Wolvetang, EJ and Jones, GM (2005). Mitochondrial dysfunction in mouse oocytes results in preimplantation embryo arrest in vitro. (vol 71, pg 1936, 2004). Biology of Reproduction, 73 (6), 1312-1312. doi: 10.1095/biolreprod.105.048561 |
|
2005 Journal Article Essential Roles of Sphingosine-1-Phosphate and Platelet-Derived Growth Factor in the Maintenance of Human Embryonic Stem CellsPebay, Alice, Wong, Raymond C. B., Pitson, Stuart M., Wolvetang, Ernst J., Peh, Gary S.-L., Fykilipcz, Adam, Koh, Karen L. L., Tellis, Irene, Nguyen, Linh T.V. and Pera, Martin F. (2005). Essential Roles of Sphingosine-1-Phosphate and Platelet-Derived Growth Factor in the Maintenance of Human Embryonic Stem Cells. Stem Cells, 23 (10), 1541-1548. doi: 10.1634/stemcells.2004-0338 |
|
2005 Journal Article ets-2 promotes the activation of a mitochondrial death pathway in Down's syndrome neuronsHelguera, Pablo, Pelsman, Alejandra, Pigino, Gustavo, Wolvetang, Ernst, Head, Elizabeth and Busciglio, Jorge (2005). ets-2 promotes the activation of a mitochondrial death pathway in Down's syndrome neurons. Journal of Neuroscience, 25 (9), 2295-2303. doi: 10.1523/JNEUROSCI.5107-04.2005 |
|
2004 Journal Article Mitochondrial Dysfunction in Mouse Oocytes Results in Preimplantation Embryo Arrest in Vitro full accessThouas, George, A., Trounson, Alan O., Wolvetang, Ernst J. and Jones, Gayle M. (2004). Mitochondrial Dysfunction in Mouse Oocytes Results in Preimplantation Embryo Arrest in Vitro full access. Biology of Reproduction, 71 (6), 1936-1942. doi: 10.1095/biolreprod.104.033589 |
|
2003 Journal Article The chromosome 21 transcription factor ETS2 transactivates the β-APP promoter: Implications for Down syndromeWolvetang, E. W., Bradfield, O. M., Tymms, M., Zavarsek, S., Hatzistavrou, T., Kola, I. and Hertzog, P. J. (2003). The chromosome 21 transcription factor ETS2 transactivates the β-APP promoter: Implications for Down syndrome. Biochimica et biophysica acta (BBA). Gene structure and expression, 1628 (2), 105-110. doi: 10.1016/S0167-4781(03)00121-0 |
|
2003 Journal Article Epstein-Barr virus LMP1 blocks p16INK4a–RB pathway by promoting nuclear export of E2F4/5Ohtani, Naoko, Brennan, Paul, Gaubatz, Stefan, Sanij, Elaine, Hertzog, Paul, Wolvetang, Ernst, Ghysdael, Jacques, Rowe, Martin and Hara, Eiji (2003). Epstein-Barr virus LMP1 blocks p16INK4a–RB pathway by promoting nuclear export of E2F4/5. Journal of Cell Biology, 162 (2), 173-183. doi: 10.1083/jcb.200302085 |
|
2003 Journal Article Regulation of p53 by macrophage migration inhibitory factor in inflammatory arthritisLeech, Michelle, Lacey, Derek, Santos, leilani, Hutchinson, Paul, Wolvetang, Ernst, David, John R., Bucala, Richard and Morand, Eric F. (2003). Regulation of p53 by macrophage migration inhibitory factor in inflammatory arthritis. Arthritis & Rheumatism, 48 (7), 1881-1889. doi: 10.1002/art.11165 |
|
2003 Journal Article Characterization of monoclonal antibodies specific to the transcription factor ETS-2 proteinSanij, Elaine, Scott, Bernadette, Wilson, Trevor, Xu, Dakang, Hertzog, Paul and Wolvetang, Ernst (2003). Characterization of monoclonal antibodies specific to the transcription factor ETS-2 protein. Immunology Letters, 86 (1), 63-70. doi: 10.1016/S0165-2478(02)00258-4 |
|
2003 Journal Article ETS2 overexpression in transgenic models and in Down syndrome predisposes to apoptosis via the p53 pathwayWolvetang, E. J., Wilson, T. J., Sanij, E., Busciglio, J., Hatzistavrou, T., Hertzog, P. J. and Kola, I. (2003). ETS2 overexpression in transgenic models and in Down syndrome predisposes to apoptosis via the p53 pathway. Human Molecular Genetics, 12 (3), 247-255. doi: 10.1093/hmg/ddg015 |
|
2003 Journal Article Overexpression of the chromosome 21 transcription factor Ets2 induces neuronal apoptosisWolvetang, E. J., Bradfield, O. M., Hatzistavrou, T., Crack, P. J., Busciglio, J., Kola, I. and Hertzog, P. J. (2003). Overexpression of the chromosome 21 transcription factor Ets2 induces neuronal apoptosis. Neurobiology of Disease, 14 (3), 349-356. doi: 10.1016/S0969-9961(03)00107-4 |
|
2002 Journal Article Erratum: Ets-2 is induced by oxidative stress and sensitizes cells to H2O2-induced apoptosis: Implications for down's syndrome, (Biochemical and Biophysical Research Communications (2001) 287:4 (1003-1008))Sanij, E., Hatzistavrou, T., Hertzog, P., Kola, I. and Wolvetang, E. J. (2002). Erratum: Ets-2 is induced by oxidative stress and sensitizes cells to H2O2-induced apoptosis: Implications for down's syndrome, (Biochemical and Biophysical Research Communications (2001) 287:4 (1003-1008)). Biochemical and Biophysical Research Communications, 291 (1) |
|
2002 Journal Article Ets-2 is induced by oxidative stress and sensitizes cells to H2O2-induced apoptosis: Implications for Down's syndrome (vol 287, pg 1003, 2001)Sanij, E, Hatzistavrou, T, Hertzog, P, Kola, and Wolvetang, EJ (2002). Ets-2 is induced by oxidative stress and sensitizes cells to H2O2-induced apoptosis: Implications for Down's syndrome (vol 287, pg 1003, 2001). Biochemical and Biophysical Research Communications, 291 (1), 191-191. doi: 10.1006/bbrc.2002.6411 |
|
2001 Journal Article Ets-2 is induced by oxidative stress and sensitizes cells to H2O2-induced apoptosis: Implications for Down's SyndromeSanij, E., Hatzistavrou, T., Hertzog, P., Kola, I. and Wolvetang, E. J. (2001). Ets-2 is induced by oxidative stress and sensitizes cells to H2O2-induced apoptosis: Implications for Down's Syndrome. Biochemical and Biophysical Research Communications, 287 (4), 1003-1008. doi: 10.1006/bbrc.2001.5680 |
